Functional and comparative genomics analyses of pmp22 in medaka fish
© Itou et al; licensee BioMed Central Ltd. 2009
Received: 11 February 2009
Accepted: 17 June 2009
Published: 17 June 2009
Pmp22, a member of the junction protein family Claudin/EMP/PMP22, plays an important role in myelin formation. Increase of pmp22 transcription causes peripheral neuropathy, Charcot-Marie-Tooth disease type1A (CMT1A). The pathophysiological phenotype of CMT1A is aberrant axonal myelination which induces a reduction in nerve conduction velocity (NCV). Several CMT1A model rodents have been established by overexpressing pmp22. Thus, it is thought that pmp22 expression must be tightly regulated for correct myelin formation in mammals. Interestingly, the myelin sheath is also present in other jawed vertebrates. The purpose of this study is to analyze the evolutionary conservation of the association between pmp22 transcription level and vertebrate myelin formation, and to find the conserved non-coding sequences for pmp22 regulation by comparative genomics analyses between jawed fishes and mammals.
A transgenic pmp22 over-expression medaka fish line was established. The transgenic fish had approximately one fifth the peripheral NCV values of controls, and aberrant myelination of transgenic fish in the peripheral nerve system (PNS) was observed. We successfully confirmed that medaka fish pmp22 has the same exon-intron structure as mammals, and identified some known conserved regulatory motifs. Furthermore, we found novel conserved sequences in the first intron and 3'UTR.
Medaka fish undergo abnormalities in the PNS when pmp22 transcription increases. This result indicates that an adequate pmp22 transcription level is necessary for correct myelination of jawed vertebrates. Comparison of pmp22 orthologs between distantly related species identifies evolutionary conserved sequences that contribute to precise regulation of pmp22 expression.
Peripheral myelination is important for rapid body movement and sensing several environmental stimuli . The pmp22 gene encodes a hydrophobic tetraspan membrane protein which is a member of the junction protein family Claudin/EMP/PMP22 . In the peripheral nerve system (PNS), PMP22 contributes to the formation and maintenance of the myelin sheath [3, 4]. It is known that in mammals an increase of the pmp22 transcription level induces a reduction in nerve conduction velocity (NCV), coupled with abnormal axonal myelination. In Charcot-Marie-Tooth disease type1A (CMT1A) patients, the majority have a heterozygous tandem duplication of chromosome 17p11.2-p12, a 1.5 Mbp region that includes pmp22, and the patients undergo slow NCV and distal muscle weakness [3, 5]. Thus, pmp22 transcription is likely to be tightly regulated to prevent over-expression. Understanding the regulatory mechanisms of this gene might improve treatment of CMT1A patients.
Promoter regions and some regulatory motifs of mammalian pmp22 have been reported. Transgenic rodent studies have shown the promoter regions and sequence conservation of the gene [6, 7]. Some in vitro studies have identified regulatory motifs for Schwann cell specific expression of pmp22 [8, 9]. However, unidentified functional sequences for modulation of pmp22 expression might be found by comparative genomics analyses.
The comparative genomics approach between jawed fishes and mammals facilitates the identification of novel conserved motifs [10, 11]. Pufferfish, a teleost fish, have a compact genome, which has few redundant non-coding regions and is useful for finding functional sequences [12, 13]. The elephant shark, a cartilaginous fish, has a genome with more conserved sequences with the human genome than the teleost fish genomes, and is expected to assist in the identification of novel essential motifs . Pufferfish and the elephant shark are, however, unsuitable for experimental procedures. Two well known experimental teleost fish, zebrafish and medaka are available for both bioinformatics analyses and laboratory research.
In the present vertebrate phylogeny, the myelin sheath is seen only among jawed vertebrates [1, 15]. It is unclear whether an adequate pmp22 transcription level is necessary for correct myelination in all jawed vertebrates. To address this issue, we established a transgenic medaka fish line overexpressing pmp22 and analyzed aberrations in their PNS. Although zebrafish is more universally used for experiments, we focused on medaka fish , because the medaka fish genome has shorter non-coding regions than the zebrafish , and thus is advantageous for bioinformatics analyses. Comparative genomics analyses were performed to identify conserved non-coding sequences. Our study reveals that pmp22 has an important role in myelin formation not only in mammals but also in fishes, and shows that the gene structure and some regulatory motifs are conserved among jawed vertebrates.
In silico identification of the pmp22 ortholog in medaka fish
Reduction in peripheral nerve conduction velocity and aberrant myelination in the ol_pmp22 over-expression fish
To observe the electrical excitability of the fish PNS, population spikes of nerve fibers activated by electrical stimulation were detected in sagittal sections of the adult fish trunk. Activated spikes were not observed with the sodium channel blocker, TTX (1 μM) with 100 μA stimulation, suggesting that the spikes were generated by electrical excitability of neurons (Figure 3C). We observed the peaks of population spikes immediately after 60 μA stimulation and estimated the NCV by the distance between two channels divided by the time lag of the peaks (Figure 3D, E, F). The wild type and GFP fish had similar NCVs (9.566 ± 1.542 m/s, n = 5 and 9.700 ± 1.457 m/s, n = 5, respectively), while the pmp22 fish had approximately one fifth the control line NCV value (1.924 ± 0.738 m/s, n = 5) (Figure 3G).
To test kinematic abnormalities, we observed medaka fish swimming in running water. Medaka fish usually swim against the current to keep their position. However, in a rapid current, the fish were swept downstream while swimming against the current. We measured flow distances of the wild type, GFP fish and pmp22 fish per time in rapid water current (0.25 m/s). The pmp22 fish had a tendency to be swept away faster than the control lines (Figure 3H), indicating that pmp22 over-expression causes weak swimming ability in medaka fish.
Alternative first exons have been conserved in ol_pmp22
Conserved sequences in the pmp22 region
Some regulatory motifs have already been identified in the promoter regions of human and rodent pmp22 exon1A [8, 24]. NF1 is a conserved non-coding sequence of myelin genes and is located between the TATA-box and the TSS of the pmp22 1A promoter. SREB is the binding site for the sterol regulatory element binding proteins which are transcription factors for cholesterol homeostasis. The FP330 motif B is a conserved regulatory motif in myelin gene promoters. CREB, which is the binding site for the cyclic AMP response element binding protein, has been conserved in several gene promoters in vertebrates [26, 27]. Thus, we analyzed the pmp22 conserved non-coding sequences in jawed vertebrates.
Pmp22 over-expression causes reduction in peripheral NCV and aberrant myelination in jawed vertebrates
Increase of pmp22 expression causes CMT1A in humans and rodents. CMT1A patients, which have a heterozygous tandem duplication of a 1.5 Mbp region that includes hs_pmp22, have reduced peripheral NCV, aberrant myelination and distal muscle atrophy [3, 5]. CMT1A rodent models with pmp22 over-expression, have been established to understand and treat this neuropathy [30–32]. In mouse models with a human YAC containing hs_pmp22, the degree of the CMT1A phenotype depends on the hs_pmp22 transcription level associated with YAC copy number [33, 34]. The C22 mouse, a CMT1A model with 7 YAC copies, shows significant demyelinating neuropathy. A mouse study with tetracycline inducible pmp22 over-expression reveals that demyelination occurs only when pmp22 is highly expressed in adult, and that the neuropathic phenotype is reversible . Rat in vivo and in vitro studies show that progesterone promotes pmp22 1A transcription in Schwann cells [36, 37]. A CMT1A rat model, having 1.6 fold higher pmp22 transcription than wild type rats, is used for the progesterone antagonist test. The progesterone antagonist reduces pmp22 expression level. The treated CMT1A rats show higher motor performance than controls with the relief of muscle atrophy and sciatic nerve demyelination . Ascorbic acid improves the CMT1A phenotype through the inhibition of cyclic AMP stimulation of pmp22 transcription. The ascorbic acid treated C22 mice have more activity, correct myelination and a longer life span than control neuropathy mice . The principles of these treatments are based on the reduction of pmp22 transcription. Recently, another approach for the treatment of this neuropathy has been reported. In the C22 Schwann cells, there are large aggresomes, including PMP22 and ubiquitin, at perinuclear regions . Also, the HSP90 inhibitor promotes heat shock protein expression, and corrects Schwann cell myelination with clearance of aggregated PMP22 .
The myelin sheath enables saltatory conduction in animals . The jawed vertebrates have myelinated axons and conserved pmp22. To analyze the relationship between pmp22 transcription level and peripheral myelination in medaka fish, pmp22 fish were established. Compared with control lines, ol_pmp22 overexpressing fish, having approximately two-fold higher transcription of ol_pmp22, have one fifth peripheral NCV and aberrant PNS myelination, in spite of the transgene lacking intron 2–4 and the region downstream of the coding regions (Figure 3, 4). CMT1A patients and rodent models have hypo- and hypermyelination, attenuated fibers and onion bulb formations in the PNS [3, 32]. In PNS, PMP22 interacts with α6β4 integrin to stabilize the attachment between the basal lamina and myelin sheath . The β4 integrin and distroglycan double knockout mice lose myelin sheath stability with loose basal laminas and macrophage infiltration . The macrophage-mediated myelin disruption occurs in human CMT1A with the pmp22 duplication , the C61 mouse with 4 YAC copies , the myelin glycoprotein P0 heterozygous deficient mouse , and the gap junction protein CX32 null mouse . P0 and CX32 contribute to myelin formation in PNS . Similar to these phenotypes observed in the PNS in mammals, we found loose basal laminas and macrophages including myelin debris in the PNS of pmp22 fish (Figure 4). Therefore our observations of the pmp22 fish suggest that the association of pmp22 expression levels with myelin maintenance is common among jawed vertebrates. Although, the pmp22 fish have normal growth, feeding and mating throughout life in the laboratory, it seems that prevention of pmp22 over-expression provides some advantages for selective pressure because of reduced NCV, weak swimming ability against the current and aberrant myelination caused by pmp22 over-expression in medaka fish.
The exon-intron structure and non-coding motifs of pmp22 are conserved
The PMP22 sequence is highly conserved in jawed vertebrates, but less so in the chordate . Alignments show that there are many conserved non-coding regions among mammals, and some regions in jawed vertebrates. Human and rodent pmp22 consist of alternative untranslated first exons, 1A and 1B , and four coding exons. Mammalian exon1A, located upstream of exon1B, is specifically expressed in Schwann cells. The alternative first exons also exist in ol_pmp22, suggesting that the common ancestor of teleost fishes and mammals had these exons, and the gene structure has been conserved in present jawed vertebrates. The ol_pmp22 1A transcript was upregulated in near hatching stage fish (Figure 6), which have immature Schwann cells with radial sorting in correspondence with zebrafish and rodent development [25, 49–51]. Radial sorting is a step for differentiation from immature Schwann cells into myelinating Schwann cells. In this step, immature Schwann cells establish a 1:1 relationship with axons. On the other hand, as well as the rodent pmp22 1A transcript, which is elevated during myelination after birth [24, 52], ol_pmp22 1A transcription increased after hatching (Figure 6). These results suggest that there is similar temporal expression of pmp22 1A transcription among jawed vertebrates.
Our bioinformatics analyses found that ol_pmp22 has two known conserved regulatory motifs (Figure 7). The FP330 motif B (CTCTCAGGC) is conserved immediately upstream of the TSS of pmp22 exon1A [9, 24]. This motif is found in promoters of essential myelin genes in mammals. While in the promoter region of hs_pmp22 exon1A, a CREB half-site (TGAC) has been identified as the silencer responding to low cyclic AMP levels . A CREB half-site and CREB TG variant (TGATGTCA)  were found in the mm_ and ol_pmp22 exon1A promoter region, respectively. However, it is unclear whether both of these CREB sites are functional.
In mammalian Schwann cells, pmp22 1A transcription is activated by the zinc finger transcription factor EGR2, which is the major positive regulator for essential myelin genes . The direct target genes of EGR2 are p0, mbp, mag, prx and dhh, but not pmp22 [54, 55]. In the ol_pmp22 region, the EGR2 binding motif was not found in our analyses. In a transgenic mouse study, over-expression of POU-domain protein POU3f1 downregulates pmp22 transcription . There are many candidate sequences for POU3f1 binding in the promoter region of ol_pmp22 (data not shown); however it is unknown which sites are functional. MicroRNAs miR-9 and miR-29a inhibit pmp22 translation [57, 58]. The binding sequences for miR-9 and miR-29a are conserved among human, rodent and chicken pmp22, but not among amphibian and jawed fish pmp22.
Furthermore, in this study, two additional conserved sequences were found. The pmp22 gene has highly conserved sequence in the 3'UTR, the length of which is about 70 bp, and includes an mRNA destabilization signal (Figure 10A). This 3'UTR sequence is unique in the genome. It is possible that the 3'UTR conservation contributes to modulating the PMP22 level by transcriptional or posttranscriptional regulation. By using a motif finding program, the novel conserved short sequence was found in intron1A of human, rodent and medaka fish pmp22 and in the upstream region of exon1B of the other species pmp22 (Figure 10B). In our transient expression assay, fish having the GFP expression construct, lacking the region downstream of exon1A, had no fluorescence until the hatching stage. These results suggest that the regulatory mechanism of 1A transcription in the embryonic stage is different from that after the hatching stage, and that this novel motif must be responsible for the embryonic stage expression of pmp22.
The DNA-binding domains of several transcription factors and short DNA sequences for transcription factor binding are usually conserved in animal genomes [59, 60]. Comparison of the corresponding genome regions between fishes and mammals is useful for identification of functionally conserved sequences. We have successfully found novel conserved non-coding motifs (Figure 10), however further studies are necessary to fully understand pmp22 expression.
We investigated the relation of pmp22 transcription level with PNS pathophysiology in medaka fish. Similar to the mammalian CMT1A phenotype caused by pmp22 over-expression, reduction in peripheral NCV and aberrant myelin formation were observed in the pmp22 over-expression fish, having two fold higher transcription of ol_pmp22. These results suggest that the contribution of adequate pmp22 expression in PNS is common among jawed vertebrates. Moreover, we elucidated the structural conservation of the gene among human, rodent and medaka fish, and found novel conserved non-coding motifs. These results indicate that the common ancestor for jawed vertebrates had acquired myelin formation with the associated gene functions including pmp22 and it has been conserved in present species.
Medaka fish breeding and selection
All fish lines were maintained at around 26°C under a 14 h light and 10 h dark cycle. Collected eggs were grown with 0.3% sea salt water. GFP transgenic fish were screened by fluorescent microscopy observation at embryonic and juvenile stages. Genotyping to select pmp22 over-expression fish was performed by PCR amplification of tail fin genomic DNA using primers ip166 (5'-CATGGATTACAAAGACGACGA-3') and ip167 (5'-ATGAGTCCGCTGATGAGCAC-3'). Manipulation of fish was performed following both national and institutional guidelines.
DNA, RNA preparation and cDNA synthesis
Fish genomic DNA was prepared by phenol-chloroform and ethanol precipitation. Plasmids were prepared with the QIAprep Spin Miniprep Kit (Qiagen, Hilden, Germany). Total RNA was extracted by ISOGEN (Nippongene, Tokyo, Japan). First strand cDNA was synthesized by using the First-Strand cDNA Synthesis Kit (GE Healthcare, Tokyo, Japan).
To construct the EGFP basic vector, an NcoI/XbaI digested EGFP coding fragment was obtained from a pEGFP vector (Clontech, Palo Alto, CA, USA) and inserted into the NcoI/XbaI digested pGL3-basic vector (Promega, Madison, WI, USA).
The 11 kbp region upstream of the translation start codon of ol_pmp22 was amplified by PCR with HdrR genomic DNA as the template and primers ip097 (5'-ATACGCGTATCATTTTCAAGGTCACTGGG-3') and ip098 (5'-AAGGATCCTTCACGGCCAGTCTAAGAAGAGAGGAGACA-3'). To construct the p11-0 EGFP expression vector, the amplified 11 kbp DNA fragment was digested with MluI/BamHI, and inserted into the MluI/BglII digested EGFP basic vector. The amplified 11 kbp DNA was digested with BamHI and partially digested with BglII, to obtain 6.5-0, 3-0 and 6.5-3 fragments. To construct the p6.5-0 and p3-0 vector, the fragments were inserted into the BglII digested and BAP treated EGFP basic vector. The 0.5 kbp fragment including the splice accepter sequence was obtained by PCR amplification of genomic DNA using primers ip119 (5'-TAAGATCTCTTTGCTCTGGGTTAAAGTT-3') and ip098, digested with BglII/BamHI and inserted into the BglII digested and BAP treated EGFP basic vector. To construct the p6.5-3 EGFP expression vector, the 6.5-3 fragment was inserted into the BglII digested and BAP treated EGFP vector containing the 0.5 kbp region upstream of the translation start codon. To construct p11-5, the 6 kbp fragment including ol_pmp22 exon1A and its upstream region was obtained by PCR amplification of genomic DNA using primer ip097 and ip134 (5'-TTTGGATCCAGTGAGGCTCTACCTGCTCG-3'), digested with MluI/BamH I and inserted into MluI/BglII digested EGFP basic vector.
The FRT flanked EGFP-BGHp(A) – FLAG-ol_pmp22 vector was constructed for establishing the pmp22 over-expression line. The FLAG-ol_pmp22 fragment was obtained by RT-PCR of medaka 8 dpf whole embryos using primers ip017 (5'-CCATGGATTACAAAGACGACGACGACAAAATGCTGATCTTA-3') and ip018 (5'-TCTAGATCATTCTCGCTTCCT-3'). The PCR product was digested with NcoI/XbaI and inserted into the NcoI/XbaI digested pGL3-basic vector. The fragment of BGHp(A) was amplified by PCR with phrGFPII-1 (Stratagene, La Jolla, CA, USA) as template and primers ip041 (5'-GGTCTAGATTCCCTTTAGTGAG-3') and ip042 (5'-GCGGATCCGGCGCCCCAGCATG-3'), digested with XbaI/BamHI and inserted into the XbaI/BamHI digested EGFP basic vector. To construct the FRT-flanked EGFP-BGHp(A) vector, the fragment was obtained by PCR amplification with the EGFP-BGHp(A) vector as template and primers ip044 (5'-CGAGATCTGAAGTTCCTATTCCGAAGTTCCTATTCTCTA GAAAGTATAGGAACTTCAAGCTTGGCATTCCGGTACTG-3') and ip045 (5'-AGAGCGCTCGAGGGCCCGTCTCCCATGAAGTTCCTATACTTTCTAGAGAA TAGGAACTTCGGAATAGGAACTTCGAATTCCGACGATAGTCATGCCC-3'), digested with BglII/Eco47III and inserted into the BglII/Eco47III digested pGL3-basic vector. An NcoI/Eco47III digested FLAG-ol_pmp22 fragment was obtained, and it was inserted into the BsmBI/Eco47III digested FRT-flanked EGFP-BGHp(A) vector. This vector was digested with MluI/BglII and ligated with the MluI/BamHI digested 11 kbp PCR product of the region upstream of the translation start codon (see additional file 2, the plasmid construct was drawn with PlasMapper ).
Medaka fish fertilized eggs were collected immediately after spawning and placed into cold Yamamoto's solution (133 mM NaCl, 2.7 mM KCl, 2.1 mM CaCl2, 0.2 mM NaHCO3, pH 7.3). The solution (0.1 M K3PO4, 0.05% phenol red) with either plasmid DNA (30 ng/μl) or mRNA (400 ng/μl) was injected into the cytoplasm of one – cell stage eggs through the chorion. For in vitro capped mRNA synthesis, template DNA including the T7 promoter and FLP recombinase coding sequence were amplified by PCR with pOG44 as template and primers ip131 (5'-ATTAATACGACTCACTATAGGGCTCTCCACAGGTGTCCACTC-3') and ip132 (5'-ACCCGCACATACAGCTCACT-3'). Flp mRNA was synthesized by using the mMESSAGE mMACHINE T7 kit (Ambion, Austin, TX, USA) and polyadenylated by the Poly (A) Tailing kit (Ambion). A pressure injector, FemtoJet (Eppendorf, Hamburg, Germany), was used with borosilicate glass capillaries GC100F-10 (Harvard Apparatus, Kent, UK).
Adult trunks were removed along with the bones and fixed in 4% paraformaldehyde in phosphate buffered saline (PBS) (pH 7.4) at 4°C for several hours. Fixed samples were decalcificated by 6% sucrose at 4°C overnight. Infiltration and embedding in glycol methacrylate were performed with Technovit 8100 (Heraeus Kulzer, Werheim, Germany). Embedded samples were sliced horizontally (10 μm) by a rotary microtome, Leica RM2165 (Leica, Nussloch, Germany) equipped with a disposable microtome blade N35 (Feather, Osaka, Japan), stretched with distilled water on slide glasses, and dried at room temperature (RT) overnight. After soaking with PBS, samples were incubated with 0.1 mg/ml proteinase K at 37°C for 15 min, rinsed with PBS, incubated with blocking solution (1% horse serum in PBS with 0.5% Tween 20) at RT for 1 h, incubated with 1/500 anti-GFP monoclonal antibody (Nacalai tesque, Kyoto, Japan) in blocking solution at 4°C overnight, rinsed with PBS with 0.5% Tween 20, incubated with 1/500 Alexa fluor 488 conjugated anti-mouse IgG antibody (Invitrogen, Eugene, OR, USA) in blocking solution at RT for 1 h, and rinsed with PBS. Bright-field and fluorescence images were observed using a confocal microscope FV1000 (Olympus, Tokyo, Japan) and data were obtained by Fluoview ver 1.6b software (Olympus).
Total RNA was prepared from whole bodies of p6.5-3 injected fish at 14 dpf. The SMART RACE cDNA Amplification kit (Clontech) and SuperScript II Reverse Transcriptase (Invitrogen) were used for first strand cDNA synthesis. RACE PCR was performed by using the Advantage 2 PCR kit (Clontech) with primer ip128 (5'-TAGGTCAGGGTGGTCACGAGGGT-3').
The target mRNA quantification was performed by using the Power SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA). The following primers were used: ip150 (5'-GCTCTCTGATGATTCTTGCTTTTG-3') and ip151 (5'-AGGAGCAGAATGTCCAGAATGC-3') for the 1A transcript, ip152 (5'-CTACTGCAGGTCCACTCTTTTGG-3') and ip153 (5'-GGCCAGTTTCAAGCAAATCG-3') for the 1B transcript, ip160 (5'-TCCTCTTCTTCTGTCAGCTCTTCA-3') and ip161 (5'-GCTCCGCTCATCACAAACAA-3') for total ol_pmp22 transcript, ip154 (5'-GCCCCACCAGAGCGTAAATAC-3') and ip155 (5'-CATCGTACTCCTGCTTGCTGAT-3') for beta-actin. Relative quantification was calculated according to the manufacturer's instructions.
The electrical excitability of fish nerve was measured according to Imamura Y., 2008 . Sagittal fish slices (500 μm) were cut by a vibrating microtome, DTK-1000 (DSK, Kyoto, Japan) in an oxygenated (95% O2/5% CO2) physiological solution, artificial cerebrospinal fluid (ACSF) at 4°C, containing: 126 mM NaCl, 2.5 mM KCl, 1 mM MgCl2, 26 mM NaHCO3, 1,25 mM NaH2PO4, 2 mM CaCl2 and 10 mM D-glucose. The sample was attached to a 64 channel-electrode dish perfused with ACSF (3 ml/min). Peripheral nerve fibers were stimulated with 0.1 Hz, 60 or 100 μA, and population spikes of fish nerve fibers at 300 μm, 600 μm, and 900 μm distance between two channels were recorded in the perfusion of ACSF. The recording was stored in Windows XP hardware and data analysis was performed with Mobius software of the MED64 system (Alpha MED Sciences, Osaka, Japan). Statistical analysis was performed by Student's t-test.
Swimming ability test
The medaka fish swimming ability test was performed in running water (0.25 m/s) in a straight horizontal watercourse (depth 30 mm, width 70 mm, length 1 m) at room temperature. Adult male fish were used. The volume of water flow from a 15 mm diameter hose was 188 ml per second. Medaka fish were put into a decelerated water current in a net for 30 seconds and gently released into the rapid water current. The movie of a top view of fish swimming was acquired by a digital video camera, NV-GS250-S (Matsushita, Osaka, Japan). A picture of each time point was obtained by MotionDV STUDIO 5.3J LE for DV software (Matsushita), and analyzed by the scion image software (Scion, Frederick, MD, USA). Statistical analysis was performed by Student's t-test.
Adult trunks were removed along with the bones and cut into 1–2 mm pieces. Samples were fixed in 2% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4) for 2 h, washed in 0.1 M phosphate buffer (pH 7.4) for 20 min 5 times and postfixed in 1% OsO4 in phosphate buffer (pH 7.4) for 2 h. Then samples were dehydrated: 50% ethanol for 10 min, 60% ethanol for 10 min, 70% ethanol for 10 min, 80% ethanol for 10 min, 90% ethanol for 10 min, 99% ethanol for 10 min and 100% ethanol for 20 min twice. Dehydrated samples were transferred to propylene-oxide for 20 min twice, 1:1 propylene-oxide:epoxyresin for 1 h, 1:3 propylene-oxide:epoxyresin for 1 h and epoxyresin overnight. For embedding, samples were left at 60°C with fresh epoxyresin three overnight. Ultra thin sections (80 nm) were obtained on an Ultra microtome EM UC6 (Leica, Vienna, Austria), counterstained by Reynolds method and examined on an H-7650 (Hitachi, Tokyo, Japan). Medaka fish motor nerve fibers were determined on the locations according to the studies for zebrafish motor nerve fibers [64, 65].
Sequences of the EMP/PMP22 family were obtained by BLAST and BLAT, using human amino acid sequences of the family as the queries. For phylogenic analysis, mRNA sequences were translated into amino acid sequences. The analyses for conserved motifs were performed by the scan for matches , Weeder  and jasper . Multiple alignment of pmp22 was performed by LAGAN  and presented by VISTA .
List of abbreviations
- pmp22 :
peripheral myelin protein 22
Charcot-Marie-Tooth disease type1A
nerve conduction velocity
peripheral nerve system
epithelial membrane protein
FLP recognition target
enhanced green fluorescent protein
expression sequence tags
transcription start site
cyclic AMP response element binding
yeast artificial chromosome
artificial cerebrospinal fluid
polymerase chain reaction.
We would like to thank Dr Junya Kobayashi, Dr Kenshi Komatsu and Dr Makoto Noda for technical advice and discussion. The electron microscopy study was supported by the Laboratory of Electron Microscopy, Center for Anatomical Studies, Graduate School of Medicine, Kyoto University. This work was supported by Ministry of Economy, Trade and Industry of Japan, and Grants-in-Aid for Scientific Research on Priority Areas "Comparative Genomics" from Ministry of Education, Culture, Sports, Science and Technology of Japan. Sequence data were obtained from INSD (DDBJ/EMBL/GenBank) and the UCSC Genome Browser http://genome.ucsc.edu/.
- Hartline DK, Colman DR: Rapid conduction and the evolution of giant axons and myelinated fibers. Curr Biol. 2007, 17 (1): R29-35. 10.1016/j.cub.2006.11.042.View ArticlePubMedGoogle Scholar
- Ben-Porath I, Kozak CA, Benvenisty N: Chromosomal mapping of Tmp (Emp1), Xmp (Emp2), and Ymp (Emp3), genes encoding membrane proteins related to Pmp22. Genomics. 1998, 49 (3): 443-447. 10.1006/geno.1998.5238.View ArticlePubMedGoogle Scholar
- Young P, Suter U: The causes of Charcot-Marie-Tooth disease. Cell Mol Life Sci. 2003, 60 (12): 2547-2560. 10.1007/s00018-003-3133-5.View ArticlePubMedGoogle Scholar
- Berger P, Niemann A, Suter U: Schwann cells and the pathogenesis of inherited motor and sensory neuropathies (Charcot-Marie-Tooth disease). Glia. 2006, 54 (4): 243-257. 10.1002/glia.20386.View ArticlePubMedGoogle Scholar
- Birouk N, Gouider R, Le Guern E, Gugenheim M, Tardieu S, Maisonobe T, Le Forestier N, Agid Y, Brice A, Bouche P: Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases. Brain. 1997, 120 (Pt 5): 813-823. 10.1093/brain/120.5.813.View ArticlePubMedGoogle Scholar
- Maier M, Castagner F, Berger P, Suter U: Distinct elements of the peripheral myelin protein 22 (PMP22) promoter regulate expression in Schwann cells and sensory neurons. Mol Cell Neurosci. 2003, 24 (3): 803-817. 10.1016/S1044-7431(03)00246-X.View ArticlePubMedGoogle Scholar
- Orfali W, Nicholson RN, Guiot MC, Peterson AC, Snipes GJ: An 8.5-kb segment of the PMP22 promoter responds to loss of axon signals during Wallerian degeneration, but does not respond to specific axonal signals during nerve regeneration. J Neurosci Res. 2005, 80 (1): 37-46. 10.1002/jnr.20425.View ArticlePubMedGoogle Scholar
- Saberan-Djoneidi D, Sanguedolce V, Assouline Z, Levy N, Passage E, Fontes M: Molecular dissection of the Schwann cell specific promoter of the PMP22 gene. Gene. 2000, 248 (1–2): 223-231. 10.1016/S0378-1119(00)00116-5.View ArticlePubMedGoogle Scholar
- Hai M, Bidichandani SI, Patel PI: Identification of a positive regulatory element in the myelin-specific promoter of the PMP22 gene. J Neurosci Res. 2001, 65 (6): 508-519. 10.1002/jnr.1181.View ArticlePubMedGoogle Scholar
- Muller F, Blader P, Strahle U: Search for enhancers: teleost models in comparative genomic and transgenic analysis of cis regulatory elements. Bioessays. 2002, 24 (6): 564-572. 10.1002/bies.10096.View ArticlePubMedGoogle Scholar
- Woolfe A, Goodson M, Goode DK, Snell P, McEwen GK, Vavouri T, Smith SF, North P, Callaway H, Kelly K, et al.: Highly conserved non-coding sequences are associated with vertebrate development. PLoS Biol. 2005, 3 (1): e7-10.1371/journal.pbio.0030007.PubMed CentralView ArticlePubMedGoogle Scholar
- Christoffels A, Koh EG, Chia JM, Brenner S, Aparicio S, Venkatesh B: Fugu genome analysis provides evidence for a whole-genome duplication early during the evolution of ray-finned fishes. Mol Biol Evol. 2004, 21 (6): 1146-1151. 10.1093/molbev/msh114.View ArticlePubMedGoogle Scholar
- Ovcharenko I, Stubbs L, Loots GG: Interpreting mammalian evolution using Fugu genome comparisons. Genomics. 2004, 84 (5): 890-895. 10.1016/j.ygeno.2004.07.011.View ArticlePubMedGoogle Scholar
- Venkatesh B, Kirkness EF, Loh YH, Halpern AL, Lee AP, Johnson J, Dandona N, Viswanathan LD, Tay A, Venter JC, et al.: Ancient noncoding elements conserved in the human genome. Science. 2006, 314 (5807): 1892-10.1126/science.1130708.View ArticlePubMedGoogle Scholar
- Bullock TH, Moore JK, Fields RD: Evolution of myelin sheaths: both lamprey and hagfish lack myelin. Neurosci Lett. 1984, 48 (2): 145-148. 10.1016/0304-3940(84)90010-7.View ArticlePubMedGoogle Scholar
- Wittbrodt J, Shima A, Schartl M: Medaka–a model organism from the far East. Nat Rev Genet. 2002, 3 (1): 53-64. 10.1038/nrg704.View ArticlePubMedGoogle Scholar
- Takeda H: Draft genome of the medaka fish: a comprehensive resource for medaka developmental genetics and vertebrate evolutionary biology. Dev Growth Differ. 2008, 50 (Suppl 1): S157-166.View ArticlePubMedGoogle Scholar
- Vandepoele K, De Vos W, Taylor JS, Meyer A, Peer Van de Y: Major events in the genome evolution of vertebrates: paranome age and size differ considerably between ray-finned fishes and land vertebrates. Proc Natl Acad Sci USA. 2004, 101 (6): 1638-1643. 10.1073/pnas.0307968100.PubMed CentralView ArticlePubMedGoogle Scholar
- Postlethwait J, Amores A, Cresko W, Singer A, Yan YL: Subfunction partitioning, the teleost radiation and the annotation of the human genome. Trends Genet. 2004, 20 (10): 481-490. 10.1016/j.tig.2004.08.001.View ArticlePubMedGoogle Scholar
- Naef R, Suter U: Many facets of the peripheral myelin protein PMP22 in myelination and disease. Microsc Res Tech. 1998, 41 (5): 359-371. 10.1002/(SICI)1097-0029(19980601)41:5<359::AID-JEMT3>3.0.CO;2-L.View ArticlePubMedGoogle Scholar
- Buchholz F, Ringrose L, Angrand PO, Rossi F, Stewart AF: Different thermostabilities of FLP and Cre recombinases: implications for applied site-specific recombination. Nucleic Acids Res. 1996, 24 (21): 4256-4262. 10.1093/nar/24.21.4256.PubMed CentralView ArticlePubMedGoogle Scholar
- Wakamatsu Y, Pristyazhnyuk S, Kinoshita M, Tanaka M, Ozato K: The see-through medaka: a fish model that is transparent throughout life. Proc Natl Acad Sci USA. 2001, 98 (18): 10046-10050. 10.1073/pnas.181204298.PubMed CentralView ArticlePubMedGoogle Scholar
- Wulf P, Bernhardt RR, Suter U: Characterization of peripheral myelin protein 22 in zebrafish (zPMP22) suggests an early role in the development of the peripheral nervous system. J Neurosci Res. 1999, 57 (4): 467-478. 10.1002/(SICI)1097-4547(19990815)57:4<467::AID-JNR6>3.0.CO;2-3.View ArticlePubMedGoogle Scholar
- Suter U, Snipes GJ, Schoener-Scott R, Welcher AA, Pareek S, Lupski JR, Murphy RA, Shooter EM, Patel PI: Regulation of tissue-specific expression of alternative peripheral myelin protein-22 (PMP22) gene transcripts by two promoters. J Biol Chem. 1994, 269 (41): 25795-25808.PubMedGoogle Scholar
- Yoshida M, Macklin WB: Oligodendrocyte development and myelination in GFP-transgenic zebrafish. J Neurosci Res. 2005, 81 (1): 1-8. 10.1002/jnr.20516.View ArticlePubMedGoogle Scholar
- Mayr B, Montminy M: Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol. 2001, 2 (8): 599-609. 10.1038/35085068.View ArticlePubMedGoogle Scholar
- Smith B, Fang H, Pan Y, Walker PR, Famili AF, Sikorska M: Evolution of motif variants and positional bias of the cyclic-AMP response element. BMC Evol Biol. 2007, 7 (Suppl 1): S15-10.1186/1471-2148-7-S1-S15.PubMed CentralView ArticlePubMedGoogle Scholar
- Dsouza M, Larsen N, Overbeek R: Searching for patterns in genomic data. Trends Genet. 1997, 13 (12): 497-498. 10.1016/S0168-9525(97)01347-4.View ArticlePubMedGoogle Scholar
- Pavesi G, Mereghetti P, Zambelli F, Stefani M, Mauri G, Pesole G: MoD Tools: regulatory motif discovery in nucleotide sequences from co-regulated or homologous genes. Nucleic Acids Res. 2006, W566-570. 10.1093/nar/gkl285. 34 Web Server
- Magyar JP, Martini R, Ruelicke T, Aguzzi A, Adlkofer K, Dembic Z, Zielasek J, Toyka KV, Suter U: Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J Neurosci. 1996, 16 (17): 5351-5360.PubMedGoogle Scholar
- Meyer Zu Horste G, Nave KA: Animal models of inherited neuropathies. Curr Opin Neurol. 2006, 19 (5): 464-473.View ArticlePubMedGoogle Scholar
- Sereda MW, Nave KA: Animal models of Charcot-Marie-Tooth disease type 1A. Neuromolecular Med. 2006, 8 (1–2): 205-216. 10.1385/NMM:8:1:205.View ArticlePubMedGoogle Scholar
- Huxley C, Passage E, Manson A, Putzu G, Figarella-Branger D, Pellissier JF, Fontes M: Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum Mol Genet. 1996, 5 (5): 563-569. 10.1093/hmg/5.5.563.View ArticlePubMedGoogle Scholar
- Huxley C, Passage E, Robertson AM, Youl B, Huston S, Manson A, Saberan-Djoniedi D, Figarella-Branger D, Pellissier JF, Thomas PK, et al.: Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice. Hum Mol Genet. 1998, 7 (3): 449-458. 10.1093/hmg/7.3.449.View ArticlePubMedGoogle Scholar
- Perea J, Robertson A, Tolmachova T, Muddle J, King RH, Ponsford S, Thomas PK, Huxley C: Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A. Hum Mol Genet. 2001, 10 (10): 1007-1018. 10.1093/hmg/10.10.1007.View ArticlePubMedGoogle Scholar
- Desarnaud F, Do Thi AN, Brown AM, Lemke G, Suter U, Baulieu EE, Schumacher M: Progesterone stimulates the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells. J Neurochem. 1998, 71 (4): 1765-1768.View ArticlePubMedGoogle Scholar
- Melcangi RC, Magnaghi V, Cavarretta I, Zucchi I, Bovolin P, D'Urso D, Martini L: Progesterone derivatives are able to influence peripheral myelin protein 22 and P0 gene expression: possible mechanisms of action. J Neurosci Res. 1999, 56 (4): 349-357. 10.1002/(SICI)1097-4547(19990515)56:4<349::AID-JNR3>3.0.CO;2-H.View ArticlePubMedGoogle Scholar
- Sereda MW, Meyer zu Horste G, Suter U, Uzma N, Nave KA: Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nat Med. 2003, 9 (12): 1533-1537. 10.1038/nm957.View ArticlePubMedGoogle Scholar
- Passage E, Norreel JC, Noack-Fraissignes P, Sanguedolce V, Pizant J, Thirion X, Robaglia-Schlupp A, Pellissier JF, Fontes M: Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat Med. 2004, 10 (4): 396-401. 10.1038/nm1023.View ArticlePubMedGoogle Scholar
- Fortun J, Go JC, Li J, Amici SA, Dunn WA, Notterpek L: Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression. Neurobiol Dis. 2006, 22 (1): 153-164. 10.1016/j.nbd.2005.10.010.View ArticlePubMedGoogle Scholar
- Rangaraju S, Madorsky I, Pileggi JG, Kamal A, Notterpek L: Pharmacological induction of the heat shock response improves myelination in a neuropathic model. Neurobiol Dis. 2008, 32 (1): 105-115. 10.1016/j.nbd.2008.06.015.PubMed CentralView ArticlePubMedGoogle Scholar
- Amici SA, Dunn WA, Murphy AJ, Adams NC, Gale NW, Valenzuela DM, Yancopoulos GD, Notterpek L: Peripheral myelin protein 22 is in complex with alpha6beta4 integrin, and its absence alters the Schwann cell basal lamina. J Neurosci. 2006, 26 (4): 1179-1189. 10.1523/JNEUROSCI.2618-05.2006.View ArticlePubMedGoogle Scholar
- Nodari A, Previtali SC, Dati G, Occhi S, Court FA, Colombelli C, Zambroni D, Dina G, Del Carro U, Campbell KP, et al.: Alpha6beta4 integrin and dystroglycan cooperate to stabilize the myelin sheath. J Neurosci. 2008, 28 (26): 6714-6719. 10.1523/JNEUROSCI.0326-08.2008.PubMed CentralView ArticlePubMedGoogle Scholar
- Vital A, Vital C, Lagueny A, Ferrer X, Ribiere-Bachelier C, Latour P, Petry KG: Inflammatory demyelination in a patient with CMT1A. Muscle Nerve. 2003, 28 (3): 373-376. 10.1002/mus.10404.View ArticlePubMedGoogle Scholar
- Kobsar I, Hasenpusch-Theil K, Wessig C, Muller HW, Martini R: Evidence for macrophage-mediated myelin disruption in an animal model for Charcot-Marie-Tooth neuropathy type 1A. J Neurosci Res. 2005, 81 (6): 857-864. 10.1002/jnr.20601.View ArticlePubMedGoogle Scholar
- Carenini S, Maurer M, Werner A, Blazyca H, Toyka KV, Schmid CD, Raivich G, Martini R: The role of macrophages in demyelinating peripheral nervous system of mice heterozygously deficient in p0. J Cell Biol. 2001, 152 (2): 301-308. 10.1083/jcb.152.2.301.PubMed CentralView ArticlePubMedGoogle Scholar
- Kobsar I, Maurer M, Ott T, Martini R: Macrophage-related demyelination in peripheral nerves of mice deficient in the gap junction protein connexin 32. Neurosci Lett. 2002, 320 (1–2): 17-20. 10.1016/S0304-3940(02)00015-0.View ArticlePubMedGoogle Scholar
- Gould RM, Morrison HG, Gilland E, Campbell RK: Myelin tetraspan family proteins but no non-tetraspan family proteins are present in the ascidian (Ciona intestinalis) genome. Biol Bull. 2005, 209 (1): 49-66. 10.2307/3593141.View ArticlePubMedGoogle Scholar
- Jessen KR, Mirsky R: Schwann cells and their precursors emerge as major regulators of nerve development. Trends Neurosci. 1999, 22 (9): 402-410. 10.1016/S0166-2236(98)01391-5.View ArticlePubMedGoogle Scholar
- Buchstaller J, Sommer L, Bodmer M, Hoffmann R, Suter U, Mantei N: Efficient isolation and gene expression profiling of small numbers of neural crest stem cells and developing Schwann cells. J Neurosci. 2004, 24 (10): 2357-2365. 10.1523/JNEUROSCI.4083-03.2004.View ArticlePubMedGoogle Scholar
- Woodhoo A, Sommer L: Development of the Schwann cell lineage: from the neural crest to the myelinated nerve. Glia. 2008, 56 (14): 1481-1490. 10.1002/glia.20723.View ArticlePubMedGoogle Scholar
- Maier M, Berger P, Nave KA, Suter U: Identification of the regulatory region of the peripheral myelin protein 22 (PMP22) gene that directs temporal and spatial expression in development and regeneration of peripheral nerves. Mol Cell Neurosci. 2002, 20 (1): 93-109. 10.1006/mcne.2002.1116.View ArticlePubMedGoogle Scholar
- Nagarajan R, Svaren J, Le N, Araki T, Watson M, Milbrandt J: EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression. Neuron. 2001, 30 (2): 355-368. 10.1016/S0896-6273(01)00282-3.View ArticlePubMedGoogle Scholar
- Jang SW, LeBlanc SE, Roopra A, Wrabetz L, Svaren J: In vivo detection of Egr2 binding to target genes during peripheral nerve myelination. J Neurochem. 2006, 98 (5): 1678-1687. 10.1111/j.1471-4159.2006.04069.x.View ArticlePubMedGoogle Scholar
- Jones EA, Jang SW, Mager GM, Chang LW, Srinivasan R, Gokey NG, Ward RM, Nagarajan R, Svaren J: Interactions of Sox10 and Egr2 in myelin gene regulation. Neuron Glia Biol. 2007, 3 (4): 377-387. 10.1017/S1740925X08000173.PubMed CentralView ArticlePubMedGoogle Scholar
- Ryu EJ, Wang JY, Le N, Baloh RH, Gustin JA, Schmidt RE, Milbrandt J: Misexpression of Pou3f1 results in peripheral nerve hypomyelination and axonal loss. J Neurosci. 2007, 27 (43): 11552-11559. 10.1523/JNEUROSCI.5497-06.2007.View ArticlePubMedGoogle Scholar
- Lau P, Verrier JD, Nielsen JA, Johnson KR, Notterpek L, Hudson LD: Identification of dynamically regulated microRNA and mRNA networks in developing oligodendrocytes. J Neurosci. 2008, 28 (45): 11720-11730. 10.1523/JNEUROSCI.1932-08.2008.PubMed CentralView ArticlePubMedGoogle Scholar
- Verrier JD, Lau P, Hudson L, Murashov AK, Renne R, Notterpek L: Peripheral myelin protein 22 is regulated post-transcriptionally by miRNA-29a. Glia. 2009.Google Scholar
- Elgar G, Vavouri T: Tuning in to the signals: noncoding sequence conservation in vertebrate genomes. Trends Genet. 2008, 24 (7): 344-352. 10.1016/j.tig.2008.04.005.View ArticlePubMedGoogle Scholar
- Copley RR: The animal in the genome: comparative genomics and evolution. Philos Trans R Soc Lond B Biol Sci. 2008, 363 (1496): 1453-1461. 10.1098/rstb.2007.2235.PubMed CentralView ArticlePubMedGoogle Scholar
- Dong X, Stothard P, Forsythe IJ, Wishart DS: PlasMapper: a web server for drawing and auto-annotating plasmid maps. Nucleic Acids Res. 2004, W660-664. 10.1093/nar/gkh410. 32 Web Server
- Takagi S, Sasado T, Tamiya G, Ozato K, Wakamatsu Y, Takeshita A, Kimura M: An efficient expression vector for transgenic medaka construction. Mol Mar Biol Biotechnol. 1994, 3 (4): 192-199.PubMedGoogle Scholar
- Imamura Y, Ma CL, Pabba M, Bergeron R: Sustained saturating level of glycine induces changes in NR2B-containing-NMDA receptor localization in the CA1 region of the hippocampus. J Neurochem. 2008, 105 (6): 2454-2465. 10.1111/j.1471-4159.2008.05324.x.View ArticlePubMedGoogle Scholar
- Myers PZ, Eisen JS, Westerfield M: Development and axonal outgrowth of identified motoneurons in the zebrafish. J Neurosci. 1986, 6 (8): 2278-2289.PubMedGoogle Scholar
- Liu DW, Westerfield M: Clustering of muscle acetylcholine receptors requires motoneurons in live embryos, but not in cell culture. J Neurosci. 1992, 12 (5): 1859-1866.PubMedGoogle Scholar
- Bryne JC, Valen E, Tang MH, Marstrand T, Winther O, da Piedade I, Krogh A, Lenhard B, Sandelin A: JASPAR, the open access database of transcription factor-binding profiles: new content and tools in the 2008 update. Nucleic Acids Res. 2008, D102-106. 36 Database
- Brudno M, Do CB, Cooper GM, Kim MF, Davydov E, Green ED, Sidow A, Batzoglou S: LAGAN and Multi-LAGAN: efficient tools for large-scale multiple alignment of genomic DNA. Genome Res. 2003, 13 (4): 721-731. 10.1101/gr.926603.PubMed CentralView ArticlePubMedGoogle Scholar
- Mayor C, Brudno M, Schwartz JR, Poliakov A, Rubin EM, Frazer KA, Pachter LS, Dubchak I: VISTA: visualizing global DNA sequence alignments of arbitrary length. Bioinformatics. 2000, 16 (11): 1046-1047. 10.1093/bioinformatics/16.11.1046.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.